No Data
No Data
Wall Street Trims Ratings for Novo Nordisk Stock, as Ozempic's Competition Grows -- Barrons.com
Viking Therapeutics (NasdaqCM:VKTX) Completes Enrollment For Phase 2 Trial Of VK2735
H.C. Wainwright Maintains Viking Therapeutics(VKTX.US) With Buy Rating, Maintains Target Price $102
Earnings Preview: VKTX to Report Financial Results Post-market on April 23
Viking Therapeutics, Inc. (VKTX) Beats Stock Market Upswing: What Investors Need to Know
SA Asks: What's the Best Weight-loss Drug Stock Right Now?